ocular diseases

Otsuka Pharmaceutical, psychedelics, RNA technology, adeno-associated viruses, AAV vector, ocular diseases, Shape Therapeutics

Otsuka and Shape Therapeutics join forces to create gene therapies for eye diseases using AI-powered platform

Anika Sharma

Just a week after Otsuka Pharmaceutical ventured into the psychedelics sector, the Japanese pharmaceutical giant has struck a collaboration deal ...